相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Molecular and Clinicopathological Analysis of Epstein-Barr Virus-Associated Posttransplant Smooth Muscle Tumors
D. Jonigk et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2012)
Spectrum of Cancer Risk Among US Solid Organ Transplant Recipients
Eric A. Engels et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Lower Malignancy Rates in Renal Allograft Recipients Converted to Sirolimus-Based, Calcineurin Inhibitor-Free Immunotherapy: 24-Month Results From the CONVERT Trial
Josefina Alberu et al.
TRANSPLANTATION (2011)
Synchronous hepatic, mesenteric and pulmonary Epstein-Barr virus-associated smooth muscle tumors in a renal transplant recipient
T. Al Hussain et al.
CLINICAL TRANSPLANTATION (2010)
Expression of EBV Latent Antigens, Mammalian Target of Rapamycin, and Tumor Suppression Genes in EBV-Positive Smooth Muscle Tumors: Clinical and Therapeutic Implications
Kong Wee Ong et al.
CLINICAL CANCER RESEARCH (2009)
Posttransplant Epstein-Barr virus-associated myogenic tumors: Case report and review of the literature
B. Sprangers et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2008)
The AKT-mTOR pathway plays a critical role in the development of leiomyosarcomas
Eva Hernando et al.
NATURE MEDICINE (2007)
Epstein-Barr virus-associated smooth muscle tumors are distinctive mesenchymal tumors reflecting multiple infection events - A clinicopathologic and molecular analysis of 29 tumors from 19 patients
AT Deyrup et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2006)
Sirolimus for Kaposi's sarcoma in renal-transplant recipients
G Stallone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Rapamycin is an effective inhibitor of human renal cancer metastasis
FL Luan et al.
KIDNEY INTERNATIONAL (2003)
Epstein-Barr virus in the pathogenesis of NPC
N Raab-Traub
SEMINARS IN CANCER BIOLOGY (2002)
分享论文
